SILENCE THERAP. SP.ADR/1 (XRP2) — Working Capital to Net Assets Ratio
SILENCE THERAP. SP.ADR/1 (XRP2) has a Working Capital to Net Assets ratio of 168.6% as of December 2025. Working capital of €105.05 Million (current assets of €118.66 Million minus current liabilities of €13.61 Million) is measured against net assets of €62.30 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See SILENCE THERAP. SP.ADR/1 defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
SILENCE THERAP. SP.ADR/1 Working Capital to Net Assets (2021–2025)
This chart shows how SILENCE THERAP. SP.ADR/1's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 168.6%, reflecting working capital of €105.05 Million against net assets of €62.30 Million EUR. For the complete balance sheet picture, see balance sheet size of SILENCE THERAP. SP.ADR/1.
Annual Working Capital to Net Assets for SILENCE THERAP. SP.ADR/1 (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for SILENCE THERAP. SP.ADR/1 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check SILENCE THERAP. SP.ADR/1 (XRP2) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 168.6% | €105.05 Million | €62.30 Million | €118.66 Million | €13.61 Million | ▲ +41.4 pp |
| 2024 | 127.2% | €170.54 Million | €134.02 Million | €187.37 Million | €16.82 Million | ▼ -240.2 pp |
| 2023 | 367.5% | €80.81 Million | €21.99 Million | €103.15 Million | €22.34 Million | ▲ +28.8 pp |
| 2022 | 338.6% | €90.45 Million | €26.71 Million | €117.01 Million | €26.56 Million | ▼ -496.1 pp |
| 2021 | 834.7% | €96.05 Million | €11.51 Million | €116.52 Million | €20.47 Million | — |